Reshma Kewalramani

CIK 1735944 · CEO & President · last filed 2026-03-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$56.77M

Companies

2

Total Filings

65

Lifetime Open-Market Net

-$74.81M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VRTX CEO & President 127,596 $444.93 $56.77M -$74.81M 59 2026-03-03
Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted Director 186,002 $0.01 $1.2K $0 6 2024-06-14

Recent Filings · Page 2 of 7

65 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-02-14 VRTX Grant (A) +19,015 $0 EDGAR
2025-02-12 VRTX Tax (F) −8,300 -$3.88M EDGAR
2025-02-06 VRTX Grant (A) +49,446 $0 EDGAR
2024-11-12 VRTX Sell (S) −15,198 -$7.83M EDGAR
2024-08-01 VRTX Sell (S) −15,202 -$7.68M EDGAR
2024-07-24 VRTX Sell (S) −15,202 -$7.56M EDGAR
2024-06-14 Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted Exer (M) +105,263 $0 EDGAR
2024-05-29 VRTX Mixed -$421.7K EDGAR
2024-05-22 VRTX Sell (S) −15,202 -$6.80M EDGAR
2024-02-27 VRTX Tax (F) −9,386 -$4.05M EDGAR
Showing 1120 of 65
Page 2 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.